Literature DB >> 23507131

Fatigue in Parkinson's disease: measurement properties of a generic and a condition-specific rating scale.

Maria H Nilsson1, Stina Bladh, Peter Hagell.   

Abstract

CONTEXT: High-quality fatigue rating scales are needed to advance the understanding of fatigue and determine the efficacy of interventions. Several fatigue scales are used in Parkinson's disease, but few have been tested using modern psychometric methodology (Rasch analysis).
OBJECTIVES: To examine the measurement properties of the generic Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) scale and the condition-specific 16-item Parkinson Fatigue Scale (PFS-16) using Rasch analysis.
METHODS: Postal survey data (n=150; 47% women; mean age 70 years) were Rasch analyzed. The PFS-16 scores were tested according to both the original polytomous and the suggested alternative dichotomized scoring methods.
RESULTS: The PFS-16 showed overall Rasch model fit, whereas the FACIT-F showed signs of misfit, which probably was the result of a sleepiness-related item and mixing of positively/negatively worded items. There was no differential item functioning by disease duration but by fatigue status (greater likelihood of needing to sleep or rest during the day among people classified as nonfatigued) in the PFS-16 and FACIT-F. However, this did not impact total score-based estimated person measures. Targeting and reliability (≥0.86) were good, but the dichotomized PFS-16 showed compromised measurement precision. Polytomous and dichotomized PFS-16 and FACIT-F scores identified six, three, and four statistically distinct sample strata, respectively.
CONCLUSION: We found general support for the measurement properties of both scales. However, polytomous PFS-16 scores exhibited advantages compared with dichotomous PFS-16 and FACIT-F scores. Dichotomization of item responses compromises measurement precision and the ability to separate people, and should be avoided.
Copyright © 2013 U.S. Cancer Pain Relief Committee. All rights reserved.

Entities:  

Keywords:  Fatigue; Parkinson's disease; Rasch model; rating scales; reliability; validity

Mesh:

Year:  2013        PMID: 23507131     DOI: 10.1016/j.jpainsymman.2012.11.004

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  9 in total

1.  The Parkinson fatigue scale: an evaluation of its validity and reliability in Greek Parkinson's disease patients.

Authors:  Ioannis E Dagklis; Efthymia Tsantaki; Dimitrios Kazis; Varvara Theodoridou; Sotirios Papagiannopoulos; Dimitrios Ntantos; Sevasti Bostantjopoulou
Journal:  Neurol Sci       Date:  2019-01-08       Impact factor: 3.307

2.  Effects of Fatigue on Balance in Individuals With Parkinson Disease: Influence of Medication and Brain-Derived Neurotrophic Factor Genotype.

Authors:  Michael Baer; Bradley Klemetson; Diana Scott; Andrew S Murtishaw; James W Navalta; Jefferson W Kinney; Merrill R Landers
Journal:  J Neurol Phys Ther       Date:  2018-04       Impact factor: 3.649

3.  What Determines Spontaneous Physical Activity in Patients with Parkinson's Disease?

Authors:  Agnieszka Gorzkowska; Joanna Cholewa; Andrzej Małecki; Aleksandra Klimkowicz-Mrowiec; Jarosław Cholewa
Journal:  J Clin Med       Date:  2020-05-01       Impact factor: 4.241

4.  Constructing prediction models for excessive daytime sleepiness by nomogram and machine learning: A large Chinese multicenter cohort study.

Authors:  Penghui Deng; Kun Xu; Xiaoxia Zhou; Yaqin Xiang; Qian Xu; Qiying Sun; Yan Li; Haiqing Yu; Xinyin Wu; Xinxiang Yan; Jifeng Guo; Beisha Tang; Zhenhua Liu
Journal:  Front Aging Neurosci       Date:  2022-07-29       Impact factor: 5.702

5.  Measurement precision of the disability for back pain scale-by applying Rasch analysis.

Authors:  Yen-Mou Lu; Yuh-Yih Wu; Ching-Lin Hsieh; Chih-Lung Lin; Shiuh-Lin Hwang; Kuang-I Cheng; Yi-Jing Lue
Journal:  Health Qual Life Outcomes       Date:  2013-07-16       Impact factor: 3.186

6.  Psychometric properties of four fear of falling rating scales in people with Parkinson's disease.

Authors:  Stina B Jonasson; Maria H Nilsson; Jan Lexell
Journal:  BMC Geriatr       Date:  2014-05-21       Impact factor: 3.921

7.  Efficacy and safety of SQJZ herbal mixtures on nonmotor symptoms in Parkinson disease patients: Protocol for a randomized, double-blind, placebo-controlled trial.

Authors:  Jing Shi; Jinzhou Tian; Ting Li; Bin Qin; Dongsheng Fan; Jingnian Ni; Mingqing Wei; Xuekai Zhang; Na Liu; Jianping Liu; Yumeng Li; Weiwei Liu; Yongyan Wang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

8.  Self-Management Education for Persons with Parkinson's Disease and Their Care Partners: A Quasi-Experimental Case-Control Study in Clinical Practice.

Authors:  Carina Hellqvist; Carina Berterö; Nil Dizdar; Märta Sund-Levander; Peter Hagell
Journal:  Parkinsons Dis       Date:  2020-04-30

9.  Increased substantia nigra echogenicity correlated with visual hallucinations in Parkinson's disease: a Chinese population-based study.

Authors:  Ting Li; Jing Shi; Bin Qin; Dongsheng Fan; Na Liu; Jingnian Ni; Tianqing Zhang; Hufang Zhou; Xiaoqing Xu; Mingqing Wei; Xuekai Zhang; Xiangzhu Wang; Jianping Liu; Yongyan Wang; Jinzhou Tian
Journal:  Neurol Sci       Date:  2019-11-22       Impact factor: 3.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.